References
  1. Chipps BE, Szefler SJ, Simons FE, Haselkorn T, Mink DR, Deniz Y, Lee JH; TENOR Study Group. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2007;119:1156-1163.
  2. Sheehan WJ, Phipatanakul W. Indoor allergen exposure and asthma outcomes. Curr Opin Pediatr 2016;28:772-777.
  3. Guarnieri M, Balmes JR. Outdoor air pollution and asthma. Lancet 2014;383:1581-1592.
  4. Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol 2017;140:895-906.
  5. Abe N, Yasudo H, Fukano R, Nakamura T, Okada S, Wakiguchi H, Okazaki F, Shirabe K, Toda S, Okamoto R, Ouchi K, Ohga S, Hasegawa S. Multi-season analyses of causative pathogens in children hospitalized with asthma exacerbation. Pediatr Allergy Immunol. 2019;30:724-731.
  6. Zheng XY, Xu YJ, Guan WJ, Lin LF. Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review. Arch Virol 2018;163:845-853.
  7. Wark PAB, Ramsahai JM, Pathinayake P, Malik B, Bartlett NW. Respiratory viruses and asthma. Semin Respir Crit Care Med 2018;39:45-55.
  8. Hasegawa S, Hirano R, Hashimoto K, Haneda Y, Shirabe K, Ichiyama T. Characteristics of atopic children with pandemic H1N1 influenza viral infection: pandemic H1N1 influenza reveals ’occult’ asthma of childhood. Pediatr Allergy Immunol 2011;22:e119-e123.
  9. Athanasiou M, Lytras T, Spala G, Triantafyllou E, Gkolfinopoulou K, Theocharopoulos G, Patrinos S, Danis K, Detsis M, Tsiodras S, Bonovas S, Panagiotopolous T. Fatal cases associated with pandemic influenza A (H1N1) reported in Greece. PLoS Curr 2010;2:RRN1194.
  10. Reichert T, Chowell G, Nishiura H, Christensen RA, McCullers JA. Does glycosylation as a modifier of original antigenic sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis 2010;10:5.
  11. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L. 2009 Pandemic Influenza A (H1N1) Virus Hospitalization Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;61:1935-1944.
  12. Okada S, Hasegawa S, Hasegawa H, Ainai A, Atsuta R, Ikemoto K, Sasaki K, Toda S, Shirabe K, Takahara M, Harada S, Morishima T, Ichiyama T. Analysis of bronchoalveolar lavage fluid in a mouse model of bronchial asthma and H1N1 2009 infection. Cytokine 2013;63:194-200.
  13. Hasegawa S, Wakiguchi H, Okada S, Gui Kang Y, Fujii N, Hasegawa M, Hasegawa H, Ainai A, Atsuta R, Shirabe K, Toda S, Wakabayashi-Takahara M, Morishima T, Ichiyama T. Cytokine profile of bronchoalveolar lavage fluid from a mouse model of bronchial asthma during seasonal H1N1 infection. Cytokine 2014;69:206-210.
  14. Fujimoto Y, Hasegawa S, Matsushige T, Wakiguchi H, Nakamura T, Hasegawa H, Nakajima N, Ainai A, Oga A, Itoh H, Shirabe K, Toda S, Atsuta R, Morishima T, Ohga S. Pulmonary inflammation and cytokine dynamics of bronchoalveolar lavage fluid from a mouse model of bronchial asthma during A(H1N1)pdm09 influenza infection. Sci Rep 2017;7:9128.
  15. Shim DH. Park YA, Kim MJ, Hong JY, Baek JY, Kim KW, Byun YH, Seong BL, Ryu S, Song MK, Hong KJ, Na W, Song D, Park JH, Sohn MH, Lee JM. Pandemic influenza virus, pH1N1, induces asthmatic symptoms via activation of innate lymphoid cells. Pediatr Allergy Immunol 2015;26:780-788.
  16. Kondo N, Nishimuta T, Nishima S, Morikawa A, Aihara Y, Akasaka T, Akasawa A, Adachi Y, Arakawa H, Ikarashi T, Ikebe T, Inoue T, Iwata T, Urisu A, Ebisawa M, Ohya Y, Okada K, Odajima H, Katsunuma T, Kameda M, Kurihara K, Kohno Y, Sakamoto T, Shimojo N, Suehiro Y, Tokuyama K, Nambu M, Hamasaki Y, Fujisawa T, Matsui T, Matsubara T, Mayumi M, Mukoyama T, Mochizuki H, Yamaguchi K, Yoshihara S. Japanese pediatric guidelines for the treatment and management of bronchial asthma 2008. Pediatr Int. 2010;52:319-26.
  17. McGovern TK, Robichaud A, Fereydoonzad L, Schuessler TF, Martin JG. Evaluation of respiratory system mechanics in mice using the forced oscillation technique. J Vis Exp 2013;75:e50172.
  18. Siddiqui S, Tsuchiya K, Risse PA, Bullimore SR, Benedetti A, Martin JG. Site of allergic airway narrowing and the influence of exogenous surfactant in the Brown Norway rat. PLoS One 2012;7:e29381.
  19. Postma DS, Kerstjens HA. Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:S187-S192.
  20. Balfour-Lynn IM, Valman HB, Wellings R, Webster AD, Taylor GW, Silverman M. Tumour necrosis factor-alpha and leukotriene E4 production in wheezy infants. Clin Exp Allergy 1994;24:121-126.
  21. Yasuda H, Suzuki T, Zayasu K, Ishizuka S, Kubo H, Sasaki T, Nishimura H, Sekizawa K, Yamaya M. Inflammatory and bronchospastic factors in asthma exacerbations caused by upper respiratory tract infections. Tohoku J Exp Med 2005;207:109-118.
  22. Risse PA, Jo T, Suarez F, Hirota N, TOlloczko B, Ferraro P, Grutter P, Martin JG. Interleukin-13 inhibits proliferation and enhances contractility of human airway smooth muscle cells without change in contractile phenotype. Am J Physiol Lung Cell Mol Physiol 2011;300:L958-L966.
  23. Gern JE, Dick EC, Lee WM, Murray S, Meyer K, Handzel ZT, Busse WW. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 1996;156:621-627.
  24. Yamaya M. Virus infection-induced bronchial asthma exacerbation. Pulm Med 2012;2012:834826.
  25. Rothlein R, Czajkowski M, O’Neill MM, Marlin SD, Mainolfi E, Merluzzi VJ. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J Immunol 1988;141:1665-1669.
  26. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-459.
  27. Malaviya R, Laskin JD, Laskin DL. Anti-TNFα therapy in inflammatory lung diseases. Pharmacol Ther. 2017;180:90-98.
  28. Bozanich E, Gualano RC, Zosky GR, Larcombe AN, Turner DJ, Hantos Z, Sly PD. Acute Influenza A infection induces bronchial hyper-responsiveness in mice. Respir Physiol Neurobiol 2008;162:190-196.
Table 1. Clinical characteristics of patients infected with A(H1N1)pdm09 at 1 month after discharge. FVC, forced vital capacity; FEV1.0, forced expiratory volume in 1 s; V50, maximal flow at 50% vital capacity.